Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID06627426

Virtual Reality for Patient Informed Consent in Neurosurgery - a Randomized Controlled Trial

Led by University Hospital, Basel, Switzerland · Updated on 2025-02-11

34

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the use of virtual reality (VR) for patient informed consent in neurosurgery. The study aims to assess whether VR improves patients' understanding of complex surgical procedures, their relationship with doctors, and reduces anxiety. The trial also explores the cost-benefit ratio and feasibility of using VR in routine clinical settings, considering the growing role of patient participation in decision-making. Participants will be randomly assigned to one of two groups: the intervention group receiving VR-based informed consent guided by a surgeon, who demonstrates the VR model and assists patients in using the system, or the control group receiving standard written informed consent. The VR process includes explanations of the surgical approach and important anatomical structures relevant to the planned surgery. During the study, patients will be assessed once on the first day for anxiety levels and the patient-doctor relationship. Researchers will measure these outcomes to compare the intervention and control groups. The study involves patients aged 18 to 75 who are undergoing specific neurosurgical procedures. Participation includes undergoing the consent process and completing assessments related to their experience and understanding.

CONDITIONS

Brief Title

Virtual Reality for Patient Informed Consent in Neurosurgery

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients between the age of 18 and 75
  • Scheduled for surgical clipping of intracranial aneurysm or resection of vascular malformations
  • Scheduled for craniotomy and resection of intracranial tumors suitable for VR segmentation
Not Eligible

You will not qualify if you...

  • Visual or auditory impairment that cannot be corrected with sufficient aids
  • Previous VR-based informed consent for surgery
  • Psychiatric illness or cognitive impairment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 1 day

Participants receive either VR-based patient informed consent guided by a surgeon or standard written informed consent before their neurosurgery. During the VR consent, participants interact with a VR system to better understand their surgical procedure and can ask questions throughout the process.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

University Hospital Basel

Basel, Switzerland, 4031

Actively Recruiting

Loading map...

Research Team

R

Raphael Guzman, Prof. Dr.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here